These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18521197)

  • 21. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors.
    Nakayama T; Toguchida J; Wadayama B; Kanoe H; Kotoura Y; Sasaki MS
    Int J Cancer; 1995 Oct; 64(5):342-6. PubMed ID: 7591308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of G1 regulatory proteins in human soft tissue sarcomas.
    Yoo J; Park SY; Kang SJ; Shim SI; Kim BK
    Arch Pathol Lab Med; 2002 May; 126(5):567-73. PubMed ID: 11958662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas.
    Broll R; Stark A; Windhövel U; Best R; Strik MW; Schimmelpenning H; Schwandner O; Kujath P; Bruch HP; Duchrow M
    Eur J Cancer; 1999 Jul; 35(7):1083-8. PubMed ID: 10533452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.
    Sabah M; Cummins R; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):64-9. PubMed ID: 17536310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas.
    Würl P; Meye A; Berger D; Bache M; Lautenschläger C; Schmidt H; Kalthoff H; Rath FW; Taubert H
    Diagn Mol Pathol; 1997 Oct; 6(5):249-54. PubMed ID: 9458382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
    Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
    Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
    Waber PG; Chen J; Nisen PD
    Cancer Res; 1993 Dec; 53(24):6028-30. PubMed ID: 8261417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfection with mdm2-antisense or wtp53 results in radiosensitization and an increased apoptosis of a soft tissue sarcoma cell line.
    Grünbaum U; Meye A; Bache M; Bartel F; Würl P; Schmidt H; Dunst J; Taubert H
    Anticancer Res; 2001; 21(3B):2065-71. PubMed ID: 11497299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor and insulin-like growth factor-I receptor expression and function in human soft-tissue sarcoma cells.
    Beech D; Pollock RE; Tsan R; Radinsky R
    Int J Oncol; 1998 Feb; 12(2):329-36. PubMed ID: 9458358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations.
    Günther T; Schneider-Stock R; Häckel C; Kasper HU; Pross M; Hackelsberger A; Lippert H; Roessner A
    Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification and Over-Expression of the MDM2 Gene in Human Soft Tissue Tumours.
    Patterson H; Barnes D; Gill S; Spicer J; Fisher C; Thomas M; Grimer R; Fletcher C; Gusterson B; Cooper C
    Sarcoma; 1997; 1(1):17-22. PubMed ID: 18521196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein.
    Keleti J; Quezado MM; Abaza MM; Raffeld M; Tsokos M
    Am J Pathol; 1996 Jul; 149(1):143-51. PubMed ID: 8686737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53.
    Stoll R; Renner C; Hansen S; Palme S; Klein C; Belling A; Zeslawski W; Kamionka M; Rehm T; Mühlhahn P; Schumacher R; Hesse F; Kaluza B; Voelter W; Engh RA; Holak TA
    Biochemistry; 2001 Jan; 40(2):336-44. PubMed ID: 11148027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of a gene encoding a p53-associated protein in human sarcomas.
    Oliner JD; Kinzler KW; Meltzer PS; George DL; Vogelstein B
    Nature; 1992 Jul; 358(6381):80-3. PubMed ID: 1614537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
    Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
    Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S; Takami K; Nakayama T; Nishisho I
    Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive and simultaneous surface plasmon resonance detection of free and p53-bound MDM2 proteins from human sarcomas.
    Wu L; Tang H; Hu S; Xia Y; Lu Z; Fan Y; Wang Z; Yi X; Zhou F; Wang J
    Analyst; 2018 Apr; 143(9):2029-2034. PubMed ID: 29637949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function and dysfunction of the human oncoprotein MDM2.
    Deb SP
    Front Biosci; 2002 Jan; 7():d235-43. PubMed ID: 11779693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.